← Open Payments lookup

EAMON DUTTA: Open Payments

NPI 1396822979 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,582 in 120 payments from 19 companies in 2025. Trend: 2023 $2,723 · 2024 $3,139 · 2025 $2,582

Food & beverage: $2,582
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc17$494
Neurocrine BioSciences, Inc.17$372
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$290
ABBVIE INC.12$231
Takeda Pharmaceuticals U.S.A., Inc.8$180
LivaNova USA, Inc.1$170
Teva Pharmaceuticals USA, Inc.11$167
Otsuka America Pharmaceutical, Inc.8$139
Axsome Therapeutics, Inc.5$107
Alkermes, Inc.4$90

Products named: SPRAVATO, INGREZZA, CAPLYTA, VRAYLAR, REXULTI, TRINTELLIX, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, INVEGA SUSTENNA.

Industry payments across GA — which companies pay providers there.